Sylvie Chalon

10.1k total citations
208 papers, 8.0k citations indexed

About

Sylvie Chalon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Sylvie Chalon has authored 208 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Cellular and Molecular Neuroscience, 93 papers in Molecular Biology and 39 papers in Neurology. Recurrent topics in Sylvie Chalon's work include Neuroscience and Neuropharmacology Research (65 papers), Neurotransmitter Receptor Influence on Behavior (53 papers) and Receptor Mechanisms and Signaling (35 papers). Sylvie Chalon is often cited by papers focused on Neuroscience and Neuropharmacology Research (65 papers), Neurotransmitter Receptor Influence on Behavior (53 papers) and Receptor Mechanisms and Signaling (35 papers). Sylvie Chalon collaborates with scholars based in France, United States and Sweden. Sylvie Chalon's co-authors include Denis Guilloteau, Jean‐Claude Besnard, Georges Durand, Sylvie Vancassel, Sylvie Bodard, Catherine Belzung, Patrick Emond, Luc Zimmer, Lucette Garreau and Samuel Leman and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Sylvie Chalon

205 papers receiving 7.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Chalon France 43 2.3k 2.0k 1.9k 1.5k 1.4k 208 8.0k
Denis Guilloteau France 43 2.1k 0.9× 1.9k 1.0× 1.4k 0.8× 1.5k 1.0× 1.6k 1.2× 234 7.6k
Robert K. McNamara United States 49 2.0k 0.9× 1.6k 0.8× 1.9k 1.0× 1.8k 1.2× 443 0.3× 180 8.6k
Dorit Ben‐Shachar Israel 47 2.0k 0.9× 2.6k 1.3× 808 0.4× 1.1k 0.7× 2.0k 1.5× 102 7.5k
John D. Elsworth United States 52 4.3k 1.8× 2.9k 1.4× 788 0.4× 1.4k 0.9× 1.6k 1.1× 155 9.1k
Manfred Gerlach Germany 44 2.0k 0.9× 1.7k 0.8× 489 0.3× 1.1k 0.7× 2.6k 1.9× 174 6.7k
Shuji Kaneko Japan 55 4.0k 1.7× 3.8k 1.9× 561 0.3× 1.9k 1.3× 519 0.4× 361 10.5k
Sahebarao P. Mahadik United States 39 1.9k 0.8× 1.8k 0.9× 732 0.4× 828 0.6× 429 0.3× 134 5.8k
Frédéric Calon Canada 63 3.4k 1.5× 3.6k 1.8× 2.1k 1.1× 4.1k 2.7× 2.7k 2.0× 192 11.8k
Roger Walz Brazil 42 2.0k 0.8× 2.0k 1.0× 599 0.3× 621 0.4× 1.0k 0.7× 225 6.0k
Andrzej Pilc Poland 54 6.1k 2.6× 3.1k 1.6× 1.3k 0.7× 915 0.6× 408 0.3× 283 10.0k

Countries citing papers authored by Sylvie Chalon

Since Specialization
Citations

This map shows the geographic impact of Sylvie Chalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Chalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Chalon more than expected).

Fields of papers citing papers by Sylvie Chalon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Chalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Chalon. The network helps show where Sylvie Chalon may publish in the future.

Co-authorship network of co-authors of Sylvie Chalon

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Chalon. A scholar is included among the top collaborators of Sylvie Chalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Chalon. Sylvie Chalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mavel, Sylvie, Kelly Ceyzériat, Sylvie Chalon, et al.. (2025). Brain, CSF, and Blood Metabolomics Signature in the TgF344-AD Rat Model of Alzheimer’s Disease. Journal of Proteome Research. 24(11). 5604–5616.
2.
Chauveau, Fabien, Alexandra Winkeler, Sylvie Chalon, Hervé Boutin, & Guillaume Becker. (2024). PET imaging of neuroinflammation: any credible alternatives to TSPO yet?. Molecular Psychiatry. 30(1). 213–228. 14 indexed citations
3.
Dupont, Anne-Claire, Sophie Sérrière, Laurent Barantin, et al.. (2021). Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers. Translational Psychiatry. 11(1). 66–66. 5 indexed citations
4.
Silindir‐Gunay, Mine, A. Yekta Özer, & Sylvie Chalon. (2015). Drug Delivery Systems for Imaging and Therapy of Parkinson';s Disease. Current Neuropharmacology. 14(4). 376–391. 52 indexed citations
5.
Rousset, Catherine I., et al.. (2008). Antenatal Bacterial Endotoxin Sensitizes the Immature Rat Brain to Postnatal Excitotoxic Injury. Journal of Neuropathology & Experimental Neurology. 67(10). 994–1000. 43 indexed citations
6.
Emond, Patrick, Denis Guilloteau, & Sylvie Chalon. (2008). PE2I: A Radiopharmaceutical forIn vivoExploration of the Dopamine Transporter. CNS Neuroscience & Therapeutics. 14(1). 47–64. 38 indexed citations
7.
Surget, Alexandre, Michael Saxe, Samuel Leman, et al.. (2008). Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal. Biological Psychiatry. 64(4). 293–301. 433 indexed citations
8.
Chitneni, Satish K., Lucette Garreau, Bernard Cleynhens, et al.. (2007). Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [18F]FECT. Nuclear Medicine and Biology. 35(1). 75–82. 15 indexed citations
9.
Vancassel, Sylvie, Samuel Leman, Stéphanie Denis, et al.. (2007). n-3 Polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. Journal of Lipid Research. 49(2). 340–348. 96 indexed citations
10.
Jhee, S. S., Amy S. Chappell, Victoria Zarotsky, et al.. (2006). Multiple‐Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects. The Journal of Clinical Pharmacology. 46(4). 424–432. 26 indexed citations
11.
Saba, Wadad, Héric Valette, Sylvie Chalon, et al.. (2006). [18F]LBT-999, a new radioligand to study the dopamine transporter with PET: Characterization in baboons. NeuroImage. 31. T132–T132. 2 indexed citations
12.
Chalon, Sylvie, Anne Aubert‐Pouëssel, Marie‐Claire Venier‐Julienne, et al.. (2002). Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Synapse. 44(3). 124–131. 31 indexed citations
13.
Zimmer, Luc, Sylvie Vancassel, S. Cantagrel, et al.. (2002). The dopamine mesocorticolimbic pathway is affected by deficiency in n−3 polyunsaturated fatty acids. American Journal of Clinical Nutrition. 75(4). 662–667. 172 indexed citations
14.
Emond, Patrick, Johnny Vercouillie, Robert B. Innis, et al.. (2002). Substituted Diphenyl Sulfides as Selective Serotonin Transporter Ligands:  Synthesis and In Vitro Evaluation. Journal of Medicinal Chemistry. 45(6). 1253–1258. 32 indexed citations
15.
Vancassel, Sylvie, G. Durand, Catherine Barthélémy, et al.. (2001). Plasma fatty acid levels in autistic children. Prostaglandins Leukotrienes and Essential Fatty Acids. 65(1). 1–7. 193 indexed citations
16.
Chalon, Sylvie. (2000). N-3 polyunsaturated fatty acids, neurotransmission and cognitive function.. Oléagineux Corps gras Lipides. 7(1). 68–73. 1 indexed citations
17.
Zimmer, Luc, Serge Delpal, Denis Guilloteau, et al.. (2000). Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neuroscience Letters. 284(1-2). 25–28. 136 indexed citations
18.
Bergström, Kim, Marko Huotari, Anu J. Airaksinen, et al.. (1999). L-[2-radio iodo] tyrosine, a new potential protein synthesis and tumour tracer for spect: Radiosynthesis and biodistribution in rodent.. European Journal of Nuclear Medicine and Molecular Imaging. 26. 971–971. 2 indexed citations
19.
Page, Guylène, Sylvie Chalon, Laurence Barrier, Alain Piriou, & François Huguet. (1998). Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools. Neurochemistry International. 33(5). 459–466. 6 indexed citations
20.
Léna, Isabelle, Sylvie Chalon, Jean‐Louis Baulieu, et al.. (1995). Iododerivative of pargyline: A potential tracer for the exploration of monoamine oxidase sites by SPECT. Nuclear Medicine and Biology. 22(6). 727–736. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Guilloteau Breakdown of academic impact, for papers by Robert K. McNamara Breakdown of academic impact, for papers by Dorit Ben‐Shachar Breakdown of academic impact, for papers by John D. Elsworth Breakdown of academic impact, for papers by Manfred Gerlach Breakdown of academic impact, for papers by Shuji Kaneko Breakdown of academic impact, for papers by Sahebarao P. Mahadik Breakdown of academic impact, for papers by Frédéric Calon Breakdown of academic impact, for papers by Roger Walz Breakdown of academic impact, for papers by Andrzej Pilc
Rankless by CCL
2026